Acurx Pharmaceuticals LLC (ACXP) Financials

$1.41

$0.01 (1.05%)

As on 02-Sep-2026 14:47EDT

Market cap

$6 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	7.67	8.09	14.10	14.58	12.09	12.81
Operating Profit (EBIT)	-7.67	-8.09	-14.10	-14.58	-12.09	-12.88
Other Income	--	--	--	--	--	--
Profit before Tax	-7.51	-7.97	-14.10	-14.58	-12.09	-12.75
Provision for Tax	--	--	-14,089.00	-0.01	0.00	-0.07
Profit after Tax (Net Income)	-7.51	-7.97	-14.10	-14.58	-12.09	-12.68
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-12.09	-12.75

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	8.15	5.27	0.62	4.67	7.32	12.41
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	2.06	--
Current Liabilities	2.83	2.42	3.24	3.04	2.06	0.84
Total Liabilities	13.82	7.69	3.86	7.71	9.38	13.25

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	--	133.44	3,854.11	--	--	--
Current Assets	10.98	7.69	3.86	7.71	9.38	13.25
Total Assets	21.97	7.69	3.86	7.71	9.38	13.25
Total Debt*	--	--	--	--	--	--
Net Current Assets	--	5.27	0.62	4.67	7.32	12.41

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-6,787.78	-10.38	-9.80	-7.54	-5.01
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	10,637.17	6.62	8.16	3.70	14.80
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-3.93	-5.31	-16.56	-21.66	-20.84	-24.81
Cash EPS ($)	--	-5.31	-16.56	-21.66	-20.84	-24.81
Adjusted Book Value ($)	--	3.51	0.72	6.93	12.61	24.28
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-4,528.21	-12.19	-14.56	-13.00	-9.81
Free Cash Flow per Share ($)	--	-4,528.21	-12.19	-14.56	-13.00	-9.81

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-270.80	-534.03	-243.33	-122.61	-167.10
ROE (%)	-111.86	-270.80	-534.03	-243.33	-122.61	-167.83
ROA (%)	-48.87	-137.98	-243.85	-170.64	-106.87	-153.92
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	149.92	--	51.63	-20.55	-87.77	-180.01
Net Profit Growth (%)	24.93	43.51	3.26	-20.55	4.64	-175.68
EPS Growth (%)	63.44	0.68	0.24	-0.04	0.16	-1.57
Book Value Growth (%)	-36.12	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.47	-0.05	-0.18	-0.19	-0.17
Price / Book Value	0.77	0.71	1.13	0.55	0.32	0.18
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.54	948.01	0.21	0.34	0.56	0.84
Close Price ($)	1.55	2.49	16.28	76.60	79.60	86.43
High Price ($)	11.73	25.00	105.60	176.40	97.80	174.80
Low Price ($)	1.33	2.49	14.40	23.40	46.60	74.20
Market Cap ($ Cr)	6.19	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	3.88	3.18	1.19	2.53	4.55	15.71
Quick Ratio	3.88	--	--	--	--	--
Interest Coverage	--	--	--	--	-19,759.80	-193.69

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.